Literature DB >> 24270968

Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological results.

J Schiffmann1, J Fischer, P Tennstedt, B Beyer, K Böhm, U Michl, M Graefen, G Salomon.   

Abstract

PURPOSE: HistoScanning™ (HS) is an ultrasound-based tissue characterization technique with encouraging results in the detection of prostate cancer (PCa). The aim of this study was to evaluate the accuracy of total tumor volume measured by HS (TVHS) in patients with PCa.
METHODS: In 148 patients with proven PCa, TVHS was measured prior to radical prostatectomy and compared with the total tumor volume in the final pathological report (TVP) using the rank-based spearman correlation test. Correlation was performed after stratification of the results by d'Amico risk categories, prostate volume, experience of HS examiner, distance of the ultrasound probe to the prostate (≤3.5 and >3.5 mm) and quality of initial HS. In addition, a re-analysis of HS data was performed by a single examiner and the TVHS from the unmodified HS data was acquired.
RESULTS: TVP was approximately twofold higher compared to TVHS. Overall, there was no significant correlation (r s = -0.0083, p = 0.9) for the TVP and the TVHS. After adjusting for d'Amico risk categories, prostate volume, experience of examiner, distance of the ultrasound probe to the prostate and quality of initial HS, no significant correlation was found. After re-analyzing of all HS data by 1 examiner, the correlation remained not significant (r s = 0.039, p = 0.6).
CONCLUSIONS: TVHS and TVP did not correlate in this cohort of patients. We cannot recommend the use of HS at least for imaging of the total tumor volume at this time. The controversial findings for prostate HS should initiate more studies to clarify these discrepancies.

Entities:  

Mesh:

Year:  2013        PMID: 24270968     DOI: 10.1007/s00345-013-1211-3

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  24 in total

1.  Editorial comment from Dr Salomon to prostate HistoScanning: a screening tool for prostate cancer?

Authors:  Georg Salomon
Journal:  Int J Urol       Date:  2013-04-17       Impact factor: 3.369

2.  Computerized transrectal ultrasound of the prostate in a multicenter setup (C-TRUS-MS): detection of cancer after multiple negative systematic random and in primary biopsies.

Authors:  Bjoern Grabski; Leif Baeurle; Annemie Loch; Bjoern Wefer; Udo Paul; Tillmann Loch
Journal:  World J Urol       Date:  2011-06-21       Impact factor: 4.226

3.  The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.

Authors:  H B Carter; A W Partin; J I Epstein; D W Chan; P C Walsh
Journal:  J Urol       Date:  1990-11       Impact factor: 7.450

4.  Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.

Authors:  Philippe Puech; Eric Potiron; Laurent Lemaitre; Xavier Leroy; Georges-Pascal Haber; Sebastien Crouzet; Kazumi Kamoi; Arnauld Villers
Journal:  Urology       Date:  2009-09-20       Impact factor: 2.649

5.  Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer.

Authors:  Johan Braeckman; Philippe Autier; Christian Garbar; Miriam Pipeleers Marichal; Cristina Soviany; Rina Nir; Dror Nir; Dirk Michielsen; Harry Bleiberg; Lars Egevad; Mark Emberton
Journal:  BJU Int       Date:  2007-10-08       Impact factor: 5.588

6.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors:  J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

7.  Utility of Histoscanning™ prior to prostate biopsy for the diagnosis of prostate adenocarcinoma.

Authors:  C Núñez-Mora; J M García-Mediero; P Patiño; C Orellana; A Garrido; A Rojo; D Rendón
Journal:  Actas Urol Esp       Date:  2013-03-16       Impact factor: 0.994

8.  Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies.

Authors:  Tillmann Loch
Journal:  World J Urol       Date:  2007-08-11       Impact factor: 4.226

9.  The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers.

Authors:  Johan Braeckman; Philippe Autier; Cristina Soviany; Rina Nir; Dror Nir; Dirk Michielsen; Karien Treurnicht; Michael Jarmulowicz; Harry Bleiberg; Senthil Govindaraju; Mark Emberton
Journal:  BJU Int       Date:  2008-08-14       Impact factor: 5.588

10.  Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer.

Authors:  T A Stamey; F S Freiha; J E McNeal; E A Redwine; A S Whittemore; H P Schmid
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

View more
  11 in total

1.  True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical efforts.

Authors:  Jonas Schiffmann; Gisa Mehring; Pierre Tennstedt; Lukas Manka; Katharina Boehm; Sami-Ramzi Leyh-Bannurah; Pierre I Karakiewicz; Peter Hammerer; Markus Graefen; Georg Salomon
Journal:  World J Urol       Date:  2015-07-28       Impact factor: 4.226

Review 2.  [Prostate biopsy: Procedure in the clinical routine].

Authors:  T Enzmann; T Tokas; K Korte; M Ritter; P Hammerer; L Franzaring; H Heynemann; H-W Gottfried; H Bertermann; M Meyer-Schwickerath; B Wirth; A Pelzer; T Loch
Journal:  Urologe A       Date:  2015-12       Impact factor: 0.639

Review 3.  HistoScanningTM to Detect and Characterize Prostate Cancer-a Review of Existing Literature.

Authors:  James S Wysock; Alex Xu; Clement Orczyk; Samir S Taneja
Journal:  Curr Urol Rep       Date:  2017-10-24       Impact factor: 3.092

Review 4.  Controversial evidence for the use of HistoScanning™ in the detection of prostate cancer.

Authors:  Jonas Schiffmann; Lukas Manka; Katharina Boehm; Sami-Ramzi Leyh-Bannurah; Pierre I Karakiewicz; Markus Graefen; Peter Hammerer; Georg Salomon
Journal:  World J Urol       Date:  2015-04-10       Impact factor: 4.226

5.  TRUS-guided transperineal prostate 12+X core biopsy with template for the diagnosis of prostate cancer.

Authors:  Gang Guo; Yong Xu; Xu Zhang
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

6.  [Value of perineal HistoScanning™ template-guided prostate biopsy].

Authors:  M F Hamann; C Hamann; D Olzem; A Trettel; K P Juenemann; C M Naumann
Journal:  Urologe A       Date:  2015-11       Impact factor: 0.639

Review 7.  Application of Multiple Ultrasonic Techniques in the Diagnosis of Prostate Cancer.

Authors:  Yushan Liu; Shi Zeng; Ran Xu
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

8.  Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate.

Authors:  J Schiffmann; P Tennstedt; J Fischer; Zhe Tian; B Beyer; K Boehm; M Sun; G Gandaglia; U Michl; M Graefen; G Salomon
Journal:  World J Urol       Date:  2014-05-29       Impact factor: 4.226

9.  A systematic review and meta-analysis of Histoscanning™ in prostate cancer diagnostics.

Authors:  Andrey Morozov; Vasiliy Kozlov; Juan Gomez Rivas; Jeremy Yuen-Chun Teoh; Evgeniy Bezrukov; Alexander Amosov; Eric Barret; Mark Taratkin; Georg Salomon; Thomas R W Herrmann; Ali Gozen; Dmitry Enikeev
Journal:  World J Urol       Date:  2021-04-07       Impact factor: 4.226

10.  Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?

Authors:  Moritz Franz Hamann; C Hamann; A Trettel; K P Jünemann; C M Naumann
Journal:  BMC Urol       Date:  2015-07-30       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.